Nirmatrelvir–remdesivir association for non-hospitalized adults with COVID-19, point of view
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s10787-022-01055-2.pdf
Reference28 articles.
1. Beigel JH, Tomashek KM, Dodd LE et al (2020) Remdesivir for the treatment of Covid-19—final report. N Engl J Med 383:1813–1826
2. Boden D, Markowitz M (1998) Resistance to human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother 42:2775–2783 (Google Scholar CrossRef PubMed)
3. Chen Z, Li Y, Schock HB, Hall D, Chen E, Kuo LC (1995) Three-dimensional structure of a mutant HIV-1 protease displaying cross-resistance to all protease inhibitors in clinical trials. J Biol Chem 270:21433–21436 (Google Scholar CrossRef)
4. Focosi D, Maggi F, McConnell S, Casadevall A (2022) Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: a GISAID exploratory analysis. Antiviral Res 198:105247. https://doi.org/10.1016/j.antiviral.2022.105247
5. Gandhi S, Klein J, Robertson A, Peña-Hernández MA, Lin MJ, Roychoudhury P, Lu P, Fournier J, Ferguson D, Mohamed Bakhash SA, Catherine Muenker M, Srivathsan A, Wunder EA, Kerantzas N, Wang W, Lindenbach B, Pyle A, Wilen CB, Ogbuagu O, Greninger AL, Iwasaki A, Schulz WL, Ko AI (2021) De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report. medRxiv [preprint]. https://doi.org/10.1101/2021.11.08.21266069 (Update in: Nat Commun. 2022 Mar 17;13(1):1547. PMID: 34909781; PMCID: PMC8669848)
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Short Update on the Use of Monoclonal Antibodies in COVID-19;The AAPS Journal;2024-03-05
2. Impact of Remdesivir on inflammatory and prognostic markers of COVID-19: Findings of an event-monitoring study;Journal of Family Medicine and Primary Care;2023-12
3. Association between microbiota and immune response to Sars-CoV-2 infection;Infectious Diseases Now;2023-06
4. SARS-CoV-2 caused a surge in antibiotic consumption causing a silent pandemic inside the pandemic. A retrospective analysis of Italian data in the first half of 2022;Annales Pharmaceutiques Françaises;2023-06
5. New drugs for type 2 diabetes mellitus: The challenge of the health care sustainability combined with a better patient care access;International Journal of Healthcare Management;2023-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3